 Preston Bratcher
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis Transmembrane Conductance Regulator | 14 | 2025 | 370 | 5.980 |
Why?
| | Aminophenols | 11 | 2026 | 201 | 3.530 |
Why?
| | Cystic Fibrosis | 17 | 2026 | 1158 | 3.170 |
Why?
| | Quinolones | 9 | 2026 | 201 | 2.940 |
Why?
| | Benzodioxoles | 8 | 2026 | 158 | 1.880 |
Why?
| | Indoles | 4 | 2026 | 501 | 1.320 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 3 | 2014 | 29 | 1.210 |
Why?
| | Streptococcus pneumoniae | 4 | 2010 | 177 | 1.080 |
Why?
| | Pyrrolidines | 3 | 2026 | 125 | 1.040 |
Why?
| | Epithelial Cells | 7 | 2025 | 1126 | 1.020 |
Why?
| | Chloride Channel Agonists | 4 | 2026 | 109 | 0.950 |
Why?
| | Pyrazoles | 3 | 2026 | 510 | 0.830 |
Why?
| | Cyclic AMP | 1 | 2025 | 209 | 0.830 |
Why?
| | Pyridines | 3 | 2026 | 605 | 0.810 |
Why?
| | Bacterial Capsules | 3 | 2010 | 33 | 0.690 |
Why?
| | Neutrophils | 6 | 2019 | 1134 | 0.690 |
Why?
| | Quinolines | 2 | 2026 | 193 | 0.680 |
Why?
| | Epithelial Sodium Channels | 1 | 2021 | 21 | 0.670 |
Why?
| | Chlorides | 1 | 2020 | 142 | 0.610 |
Why?
| | Tetraspanin 30 | 2 | 2018 | 10 | 0.600 |
Why?
| | Receptors, Interleukin-8B | 1 | 2018 | 23 | 0.580 |
Why?
| | Pseudomonas | 1 | 2018 | 33 | 0.570 |
Why?
| | Klebsiella pneumoniae | 1 | 2018 | 47 | 0.570 |
Why?
| | Cells, Cultured | 8 | 2025 | 4155 | 0.540 |
Why?
| | Matrix Metalloproteinase 9 | 3 | 2022 | 132 | 0.520 |
Why?
| | Leukocytes | 1 | 2018 | 295 | 0.510 |
Why?
| | Drug Combinations | 4 | 2026 | 392 | 0.500 |
Why?
| | Epithelium | 3 | 2021 | 314 | 0.470 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 479 | 0.460 |
Why?
| | CD11b Antigen | 1 | 2015 | 60 | 0.440 |
Why?
| | Polypropylenes | 1 | 2013 | 12 | 0.400 |
Why?
| | 1-Methyl-3-isobutylxanthine | 2 | 2025 | 24 | 0.400 |
Why?
| | Colforsin | 2 | 2025 | 48 | 0.400 |
Why?
| | Serum Albumin, Bovine | 1 | 2013 | 62 | 0.390 |
Why?
| | Coated Materials, Biocompatible | 1 | 2013 | 65 | 0.390 |
Why?
| | Antibodies, Bacterial | 2 | 2010 | 148 | 0.370 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 851 | 0.370 |
Why?
| | Pneumococcal Infections | 2 | 2010 | 103 | 0.360 |
Why?
| | Monocytes | 1 | 2015 | 538 | 0.360 |
Why?
| | Nasal Mucosa | 2 | 2024 | 112 | 0.360 |
Why?
| | Aminopyridines | 3 | 2021 | 127 | 0.340 |
Why?
| | Biosynthetic Pathways | 1 | 2010 | 25 | 0.330 |
Why?
| | Serotyping | 4 | 2010 | 32 | 0.310 |
Why?
| | Bacteriological Techniques | 1 | 2010 | 68 | 0.310 |
Why?
| | Mutation | 6 | 2022 | 4099 | 0.300 |
Why?
| | Humans | 31 | 2026 | 144957 | 0.290 |
Why?
| | Exosomes | 2 | 2019 | 104 | 0.240 |
Why?
| | Immunity, Innate | 1 | 2012 | 846 | 0.240 |
Why?
| | Bronchi | 2 | 2019 | 267 | 0.230 |
Why?
| | Inflammation | 5 | 2026 | 2880 | 0.230 |
Why?
| | Thyroid Epithelial Cells | 1 | 2025 | 1 | 0.220 |
Why?
| | Thiazolidines | 1 | 2025 | 13 | 0.220 |
Why?
| | Benzoates | 1 | 2025 | 50 | 0.220 |
Why?
| | Animals | 16 | 2025 | 38109 | 0.220 |
Why?
| | Ion Channel Gating | 1 | 2025 | 92 | 0.210 |
Why?
| | NIH 3T3 Cells | 2 | 2021 | 148 | 0.210 |
Why?
| | Rats, Inbred F344 | 1 | 2025 | 268 | 0.210 |
Why?
| | Genotype | 3 | 2021 | 1835 | 0.210 |
Why?
| | Mustard Gas | 1 | 2024 | 93 | 0.190 |
Why?
| | Leukocyte Elastase | 3 | 2026 | 75 | 0.180 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 104 | 0.180 |
Why?
| | Proline | 2 | 2019 | 83 | 0.180 |
Why?
| | Dimethyl Sulfoxide | 1 | 2022 | 41 | 0.180 |
Why?
| | Respiratory System | 2 | 2022 | 149 | 0.170 |
Why?
| | Electrophysiology | 1 | 2021 | 218 | 0.170 |
Why?
| | Vaping | 1 | 2022 | 66 | 0.170 |
Why?
| | Rats | 3 | 2025 | 5614 | 0.170 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2931 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 108 | 0.160 |
Why?
| | Heterozygote | 1 | 2021 | 315 | 0.160 |
Why?
| | Ion Transport | 1 | 2020 | 63 | 0.160 |
Why?
| | Forced Expiratory Volume | 2 | 2018 | 449 | 0.160 |
Why?
| | Isocyanates | 1 | 2020 | 9 | 0.160 |
Why?
| | Lipopolysaccharides | 3 | 2016 | 863 | 0.150 |
Why?
| | Respiratory Function Tests | 2 | 2018 | 547 | 0.150 |
Why?
| | Prodrugs | 1 | 2019 | 52 | 0.150 |
Why?
| | Down-Regulation | 1 | 2021 | 627 | 0.140 |
Why?
| | Sweat | 1 | 2018 | 51 | 0.140 |
Why?
| | Homozygote | 1 | 2018 | 199 | 0.140 |
Why?
| | Adult | 8 | 2026 | 40506 | 0.140 |
Why?
| | Biological Products | 1 | 2021 | 252 | 0.140 |
Why?
| | Trachea | 1 | 2020 | 261 | 0.140 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.140 |
Why?
| | Tissue Plasminogen Activator | 1 | 2020 | 244 | 0.140 |
Why?
| | Drug Monitoring | 2 | 2018 | 395 | 0.130 |
Why?
| | Temperature | 1 | 2021 | 679 | 0.130 |
Why?
| | Cilia | 1 | 2019 | 173 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 322 | 0.130 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 28 | 0.130 |
Why?
| | Gene Deletion | 1 | 2018 | 389 | 0.130 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 17 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 2 | 2016 | 356 | 0.130 |
Why?
| | Aztreonam | 1 | 2016 | 11 | 0.130 |
Why?
| | Male | 12 | 2026 | 72406 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2010 | 824 | 0.130 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 242 | 0.130 |
Why?
| | Doxycycline | 1 | 2017 | 62 | 0.130 |
Why?
| | Mice | 6 | 2022 | 18365 | 0.130 |
Why?
| | Pulmonary Emphysema | 1 | 2019 | 275 | 0.120 |
Why?
| | Tobramycin | 1 | 2016 | 55 | 0.120 |
Why?
| | Lung | 5 | 2024 | 4109 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 249 | 0.120 |
Why?
| | Escherichia coli | 2 | 2012 | 855 | 0.120 |
Why?
| | Azithromycin | 1 | 2016 | 104 | 0.120 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 99 | 0.120 |
Why?
| | Transcriptome | 1 | 2022 | 1046 | 0.120 |
Why?
| | Sputum | 3 | 2026 | 308 | 0.110 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 128 | 0.110 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 221 | 0.110 |
Why?
| | Microglia | 1 | 2017 | 269 | 0.110 |
Why?
| | Medication Adherence | 1 | 2018 | 539 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2015 | 284 | 0.100 |
Why?
| | Cell Line | 3 | 2017 | 2882 | 0.100 |
Why?
| | Healthy Volunteers | 1 | 2014 | 215 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 276 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 263 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 2119 | 0.100 |
Why?
| | Adsorption | 1 | 2013 | 157 | 0.100 |
Why?
| | Reference Values | 1 | 2014 | 798 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1786 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1472 | 0.100 |
Why?
| | Genes, Bacterial | 2 | 2009 | 166 | 0.090 |
Why?
| | DNA, Bacterial | 2 | 2010 | 342 | 0.090 |
Why?
| | Female | 9 | 2026 | 78376 | 0.090 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.090 |
Why?
| | Dinoprostone | 2 | 2022 | 178 | 0.090 |
Why?
| | Gene Order | 1 | 2010 | 27 | 0.080 |
Why?
| | Cattle | 1 | 2013 | 1000 | 0.080 |
Why?
| | Multilocus Sequence Typing | 1 | 2010 | 17 | 0.080 |
Why?
| | Bacterial Typing Techniques | 1 | 2010 | 44 | 0.080 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 35 | 0.080 |
Why?
| | Phagocytosis | 1 | 2012 | 299 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2026 | 11695 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 98 | 0.080 |
Why?
| | Cross Reactions | 1 | 2010 | 130 | 0.080 |
Why?
| | Korea | 1 | 2009 | 18 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2010 | 368 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2010 | 205 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 368 | 0.070 |
Why?
| | Genetic Loci | 1 | 2010 | 261 | 0.070 |
Why?
| | Cluster Analysis | 1 | 2010 | 521 | 0.070 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2009 | 61 | 0.070 |
Why?
| | Oligopeptides | 2 | 2019 | 269 | 0.070 |
Why?
| | Escherichia coli Proteins | 1 | 2009 | 206 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2191 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3415 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2010 | 515 | 0.060 |
Why?
| | Calcium | 1 | 2012 | 1184 | 0.060 |
Why?
| | Phylogeny | 1 | 2010 | 1019 | 0.060 |
Why?
| | Protein Binding | 1 | 2012 | 2276 | 0.060 |
Why?
| | Cyclopropanes | 1 | 2026 | 83 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1173 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1990 | 0.060 |
Why?
| | Mesna | 1 | 2024 | 16 | 0.050 |
Why?
| | Angiotensins | 1 | 2022 | 8 | 0.050 |
Why?
| | Sodium | 1 | 2024 | 197 | 0.050 |
Why?
| | Mesocricetus | 1 | 2022 | 46 | 0.050 |
Why?
| | Renin | 1 | 2022 | 34 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 56 | 0.050 |
Why?
| | Young Adult | 4 | 2026 | 14126 | 0.050 |
Why?
| | Thromboplastin | 1 | 2022 | 69 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1524 | 0.050 |
Why?
| | Cotinine | 1 | 2022 | 79 | 0.050 |
Why?
| | Lubiprostone | 1 | 2022 | 9 | 0.050 |
Why?
| | Cricetinae | 1 | 2022 | 304 | 0.050 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2022 | 6 | 0.050 |
Why?
| | Antidotes | 1 | 2024 | 145 | 0.040 |
Why?
| | Prostaglandins | 1 | 2022 | 94 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1500 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 923 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 144 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 301 | 0.040 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 548 | 0.040 |
Why?
| | Selenium Compounds | 1 | 2019 | 18 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.040 |
Why?
| | Thiocyanates | 1 | 2019 | 28 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 479 | 0.040 |
Why?
| | Nicotine | 1 | 2022 | 332 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 557 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 137 | 0.040 |
Why?
| | Oscillometry | 1 | 2019 | 35 | 0.040 |
Why?
| | Chemotaxis | 1 | 2019 | 122 | 0.040 |
Why?
| | Integrins | 1 | 2019 | 90 | 0.030 |
Why?
| | Smoke | 1 | 2019 | 148 | 0.030 |
Why?
| | Video Recording | 1 | 2019 | 213 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4569 | 0.030 |
Why?
| | alpha 1-Antitrypsin | 1 | 2019 | 102 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 442 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 320 | 0.030 |
Why?
| | Microscopy | 1 | 2019 | 156 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.030 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 1915 | 0.030 |
Why?
| | Matrix Metalloproteinase 12 | 1 | 2017 | 7 | 0.030 |
Why?
| | Alabama | 1 | 2017 | 33 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2016 | 44 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5997 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 359 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1253 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 636 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 336 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 251 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 320 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 5233 | 0.030 |
Why?
| | Drug Interactions | 1 | 2016 | 401 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 854 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 966 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2019 | 553 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11799 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4275 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2020 | 2540 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 382 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 476 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1619 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 940 | 0.030 |
Why?
| | Prospective Studies | 1 | 2026 | 7997 | 0.020 |
Why?
| | Adolescent | 2 | 2026 | 22453 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2017 | 2029 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2032 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2852 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 19 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1839 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 2011 | 55 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3164 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2011 | 64 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2011 | 105 | 0.020 |
Why?
| | Origin Recognition Complex | 1 | 2009 | 3 | 0.020 |
Why?
| | Chromosomes, Bacterial | 1 | 2009 | 13 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2009 | 39 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 64 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2832 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3125 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3608 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 251 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2009 | 328 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1733 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1813 | 0.010 |
Why?
| | Brain | 1 | 2017 | 2941 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1822 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1511 | 0.010 |
Why?
| | Aged | 1 | 2017 | 25947 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 35928 | 0.010 |
Why?
|
|
Bratcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|